A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa

E. R. Brunt, D. J. Brooks, A. D. Korczyn, J. L. Montastruc, F. Stocchi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa'. Together they form a unique fingerprint.

Medicine & Life Sciences